[go: up one dir, main page]

GR3021419T3 - Process for preparing highly purified fibrinogen - Google Patents

Process for preparing highly purified fibrinogen

Info

Publication number
GR3021419T3
GR3021419T3 GR960402791T GR960402791T GR3021419T3 GR 3021419 T3 GR3021419 T3 GR 3021419T3 GR 960402791 T GR960402791 T GR 960402791T GR 960402791 T GR960402791 T GR 960402791T GR 3021419 T3 GR3021419 T3 GR 3021419T3
Authority
GR
Greece
Prior art keywords
solution
fibrinogen
ionic strength
agarose
nacl
Prior art date
Application number
GR960402791T
Other languages
English (en)
Inventor
Bernard Dazey
Mohamed Hamsany
Sylvia Enfedaque-Morer
Gerard Vezon
Original Assignee
Aquitaine Dev Transf Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquitaine Dev Transf Sanguine filed Critical Aquitaine Dev Transf Sanguine
Publication of GR3021419T3 publication Critical patent/GR3021419T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Materials For Medical Uses (AREA)
GR960402791T 1992-02-04 1996-10-23 Process for preparing highly purified fibrinogen GR3021419T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201238A FR2686883B1 (fr) 1992-02-04 1992-02-04 Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.

Publications (1)

Publication Number Publication Date
GR3021419T3 true GR3021419T3 (en) 1997-01-31

Family

ID=9426316

Family Applications (2)

Application Number Title Priority Date Filing Date
GR930300095T GR930300095T1 (en) 1992-02-04 1993-09-30 Process for preparing highly purified fibrinogen
GR960402791T GR3021419T3 (en) 1992-02-04 1996-10-23 Process for preparing highly purified fibrinogen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR930300095T GR930300095T1 (en) 1992-02-04 1993-09-30 Process for preparing highly purified fibrinogen

Country Status (7)

Country Link
EP (1) EP0555135B1 (el)
AT (1) ATE141284T1 (el)
DE (2) DE555135T1 (el)
DK (1) DK0555135T3 (el)
ES (1) ES2049701T3 (el)
FR (1) FR2686883B1 (el)
GR (2) GR930300095T1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2117058A1 (en) * 1991-09-05 1993-03-18 Daphne C. Tse Topical fibrinogen complex
US5834420A (en) * 1994-07-14 1998-11-10 Croix-Rouge De Belgique Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation
DE10261126A1 (de) * 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
HUE028626T2 (en) 2008-06-23 2016-12-28 Bio-Products & Bio-Engineering Ag Stable, functionally intact, virus-inactivated fibrinogen during storage
RU2603103C2 (ru) * 2010-09-20 2016-11-20 Октафарма Аг Способ получения фибриногена с использованием сильной анионообменной смолы и содержащий фибриноген продукт
AU2013231321B2 (en) * 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo

Also Published As

Publication number Publication date
DE69303941T2 (de) 1997-03-27
EP0555135B1 (fr) 1996-08-14
DE555135T1 (de) 1994-03-31
EP0555135A1 (fr) 1993-08-11
ES2049701T1 (es) 1994-05-01
FR2686883B1 (fr) 1994-05-13
DK0555135T3 (da) 1996-11-25
FR2686883A1 (fr) 1993-08-06
GR930300095T1 (en) 1993-09-30
DE69303941D1 (de) 1996-09-19
ATE141284T1 (de) 1996-08-15
ES2049701T3 (es) 1997-01-16

Similar Documents

Publication Publication Date Title
US4673734A (en) Porous mineral support coated with an aminated polysaccharide polymer
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
CA2058676C (en) Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction
CA2182397A1 (en) Endotoxin reduction or removal process
NZ509135A (en) A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
US4359389A (en) Method for the purification of interferon
AU5965998A (en) Process for recovering growth factors, or a composition containing one or more growth factors, from milk or a milk derivative
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
GR3021419T3 (en) Process for preparing highly purified fibrinogen
DE69638291D1 (de) Verfahren zur Reinigung von Faktor IX
CA1133898A (en) Purification of interferon
US5252710A (en) Process for manufacturing von Willebrand factor
US20030152966A1 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
FI946103A (fi) Menetelmä anti-D-immunoglobuliini G-konsentraatin valmistamiseksi ja sitä sisältävä farmaseuttinen koostumus
CA2077888A1 (en) Method for purifying factor viii and preparations obtained
ATE222925T1 (de) Verbessertes verfahren zur herstellung von faktor viii
US4985144A (en) Affinity chromatography material for antigens of the bacteria of the Bordetella genus
WO1996016084A3 (en) A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
US4658017A (en) Method for the large scale purification of human fibroblast interferon
EP0868507B1 (en) Process for the purification of urease from helicobacter pylori
DE58902637D1 (de) Verfahren zum affinitaetschromatografischen reinigen von faktor xiii.
ATE175214T1 (de) Methode zur trennung von glykosylierten und unglykosylierten proteinen
JPH03244390A (ja) 大腸菌由来物質の除去方法
EP0475311A1 (en) Process for removing proteins originating from Escherichia coli
KR970006498A (ko) 활성형 인성장호르몬의 정제 방법